Basic Information
Saiba AG is a Swiss biotechnology company that specializes in researching and developing virus-like particle (VLP) vaccines for infectious and chronic diseases. Saiba AG utilizes its patented Cucumber Mosaic Virus VLP platform technology to develop SARS-CoV-2 vaccines.
Saiba AG
Zurich,Switzerland
less than 15 people
January 01, 2012
info@saiba-biotech.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios